Canada
· Delayed Price · Currency is CAD Nova Mentis Life Science Statistics
Total Valuation
Nova Mentis Life Science has a market cap or net worth of CAD 741,593. The enterprise value is 789,533.
| Market Cap | 741,593 |
| Enterprise Value | 789,533 |
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Nova Mentis Life Science has 148.32 million shares outstanding. The number of shares has increased by 2.14% in one year.
| Shares Outstanding | 148.32M |
| Shares Change (YoY) | +2.14% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.06% |
| Owned by Institutions (%) | 2.06% |
| Float | 140.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.26 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -895.11% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.00% in the last 52 weeks. The beta is 0.77, so Nova Mentis Life Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -80.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 31.14 |
| Average Volume (20 Days) | 122,421 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -628,894 |
| Pretax Income | -628,581 |
| Net Income | -628,581 |
| EBITDA | -626,268 |
| EBIT | -628,894 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 12,060 in cash and 60,000 in debt, giving a net cash position of -47,940 or -0.00 per share.
| Cash & Cash Equivalents | 12,060 |
| Total Debt | 60,000 |
| Net Cash | -47,940 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -1.05M |
| Book Value Per Share | -0.01 |
| Working Capital | -1.06M |
Cash Flow
| Operating Cash Flow | -65,382 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nova Mentis Life Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.14% |
| Shareholder Yield | -2.14% |
| Earnings Yield | -85.16% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 26, 2020. It was a reverse split with a ratio of 0.25.
| Last Split Date | Jun 26, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |